-
cds.ahrq.gov/cdsconnect/artifact/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool-updated-10
August 22, 2017 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/workgroups/216/jan-2017-cholesterol-wg-notes.docx
January 01, 2017 - risk calculation and/or presentation of the risk assessment tool:
· Application as a population health … Kaiser has both an on-demand risk calculator that can produce real-time risk scores but no recommendations … For this reason, the USPTF recommendation to calculate ASCVD risk only when 1 or more risk factor is … The WG also debated the merits of using multiple risk tools for cardiovascular risk, and whether there … of cardiovascular disease, but the potential impact of statin therapy, and in turn, the risks associated
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making.pdf
April 01, 2021 - to address this risk.
2. … Provide information resources to the patient outlining benefits, risks, effects, and
evidence behind … The Updated Risk calculation compares the original baseline risk with the updated risk reflecting
instituted … “10-year risk” Risk of showing evidence of ASCVD within the next 10 years. … Estimating Longitudinal Risks and
Benefits From Cardiovascular Preventive Therapies Among Medicare Patients
-
cds.ahrq.gov/cdsconnect/artifact/recommendation-7-opioid-therapy-risk-assessment
September 27, 2018 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/cdsconnect/artifact/mental-health-suicide-risk-assessment-documentation-template
April 06, 2018 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/cdsconnect/artifact/primary-care-management-guidance-fall-risk-increasing-drugs
June 08, 2022 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
August 29, 2020 - Implementing and Using This Artifact
Description and Purpose of the artifact
This artifact aims to address risks … Although there are concerns regarding bleeding risks associated with warfarin and antidepressants, only … Recommendation: Use only if benefit outweighs risk
· Rationale: Increased GI and non-GI bleeding risk … 20 MG Oral Tablet
None
Assess risk and take action if necessary
Increased GI and non-GI bleeding risk … risk is likely
1528
18
Warfarin / SSRI or SNRI with major bleeding risk factors
Warfarin Sodium
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
January 01, 2024 - • Provide educational resources about the risks for developing CVD and the role that statin
therapy … factors, and identification of resources to address
those risks. … Suggested Action: Provide educational materials that explain CVD risks pertinent to this
recommendation … levels” instead of clinical descriptions), along with ways to
modify those risks, such as taking a … Estimating Longitudinal Risks and
Benefits From Cardiovascular Preventive Therapies Among Medicare Patients
-
cds.ahrq.gov/cdsconnect/artifact/mental-health-positive-suicide-risk-screening-order-set
April 27, 2018 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/logic/2021-09/Million_Hearts_Baseline_10_Year_ASCVD_Risk_Change_Log.txt
January 01, 2021 - Year_ASCVD_Risk_FHIRv102 version 1.0.2 was used in
a 2019 pilot to calculate the estimated 10-year CVD risk
-
cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
January 01, 2017 - The ACC/AHA provides a statin recommendation for risk scores 5-<=7.5% and USPSTF provides one for 7.5 … <10%.
· CAMH may consider a way to allow users to change the risk score parameter if the appropriate … It influences a patient’s risk, but not as much as someone with a clinical event. … More work has been done on the inpatient side related to bleeding risks. … At a certain point, an elevated SBP is risk.
-
cds.ahrq.gov/cdsconnect/source/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool
April 07, 2025 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2024 - appointment, the primary care clinician provides educational information to the
patient about their personal risks … factors, and
identification of resources to address those risks. … Patient has a terminal condition, and the risks of preventive treatment outweigh
benefits. … CVD risk is calculated using the 2013 ACC/AHA ASCVD Risk Estimator or the ACC
Risk Estimator Plus with … Estimating Longitudinal Risks and
Benefits From Cardiovascular Preventive Therapies Among Medicare Patients
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
January 01, 2023 - • Provide educational resources about the risks for developing CVD and the role that statin
therapy … factors, and identification of resources to address
those risks. … Suggested Action: Provide educational materials that explain CVD risks pertinent to this
recommendation … levels” instead of clinical descriptions), along with
ways to modify those risks, such as taking a … Estimating Longitudinal Risks and
Benefits From Cardiovascular Preventive Therapies Among Medicare Patients
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
October 01, 2017 - Implementation Guide
Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk
Prepared … to address this risk.
2. … The Updated Risk calculation compares the original Baseline risk with the Updated risk based on interventions … Provide information resources to the patient outlining benefits, risks, effects, and evidence behind … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository_0.pdf
July 23, 2024 - Non-pharmacologic & non-opioid therapies preferred
▪ Establish treatment goals with patients
▪ Assess and discuss risks … and benefits
– Prescribe naloxone if at high risk
▪ Prescribe immediate-release opioids
▪ Prescribe … the lowest effective dose
▪ Monitor PDMP
– ≤50 MME/day preferred
– ≥90 MME/day is high risk
▪ Urine … screenings relevant to pain management – all within the past 1 year
– Opioid Risk Tool, PHQ 2, PHQ … – Always flag if present: “Factor that may place the patient at risk for an opioid-related harm.”
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
October 01, 2017 - to address this risk.
2. … on his overall cardiac risk. … The risk score display is presented as part of the assessment, showing his current risk. … Provide the patient with information resources that outline benefits, risks, effects, and evidence behind … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
January 01, 2024 - Provide educational materials that explain their risks and how reduce those risks.
3. … interventions such
as counseling to promote a healthy diet and physical activity which can mitigate those risks … Bravo to
review regarding her risk factors and ways she could reduce her risk through lifestyle
changes … factors, and identification of resources to
address those risks. … having a family history of diabetes or a history of gestational
diabetes) and how to reduce those risks
-
cds.ahrq.gov/cdsconnect/artifact/healthy-diet-and-physical-activity-cvd-prevention-adults-cardiovascular-risk
June 01, 2019 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/workgroups/211/dec-2016-cholesterol-wg-notes.docx
January 01, 2016 - ASCVD risk after interventions have been initiated)
· PQRS #438 – Statin use for Primary Prevention … · MESA CAC Score, which can double or triple a patient’s risk that was estimated by a calculator. … This score uses a sub-clinical marker, but does not estimate the risk of stroke. … The USPTF guidelines send the clinician to the calculator only if at least 1 risk factor is present. … Assessment Tool (determine if use of this tool occurs immediately if no ASCVD or if at least 1 risk